Orto AS in Home Care (Estonia)
While Orto is set to further expand its product range in home care, with an emphasis on more natural formulations, the company’s innovation strategy is primarily expected to concentrate on its beauty and personal care interests. This is the direction the company took at the end of the review period, when it relaunched Solar sun protection with new packaging and offered a new formulation for its Pure Nature range.Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.
Product coverage: Air Care, Bleach, Dishwashing, Home Insecticides, Laundry Care, Polishes, Surface Care, Toilet Care.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Home Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Company's portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.
Euromonitor International
Involved in publishing, market research, business reference and online information systems for over 40 years, Euromonitor International is recognized as a leading provider of global business intelligence and market analysis.
Euromonitor creates global reports for Western Europe, Eastern Europe, North America, Latin America, AsiaPacific, Oceania, Africa and the Middle East. The company creates market reports used for marketing and strategic planning in all sectors of industry.
Country reports look at statistical data and current industry trends for 80 countries globally. Company profiles highlight insights of leading companies regarding operations and strategies. Specializing in market research for consumer goods which includes the following sectors: alcoholic beverages, cosmetics, toiletries, disposable paper products, electrical appliances, packaged foods, hot and cold beverages, household products, OTC healthcare, pet foods, pet care and tobacco. Industry sectors include: financial services, food service, retail, leisure, lifestyles and travel/tourism.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.